Related Experiment Video
Updated: May 6, 2026
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
Phenethyl isothiocyanate modulates macrophage migration inhibitory factor and suppresses malignant phenotypes of
Jeng-Rong Lin1, Wen-Chieh Liao1,2, Yin-Hung Chu1,2
1Doctoral Program in Tissue Engineering and Regenerative Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan. chiunghui.liu@gmail.com.
Abstract:
Phenethyl Isothiocyanate (PEITC) is a well-studied compound within the isothiocyanate family. Accumulating evidence indicates that PEITC induces apoptosis and inhibits the growth of various cancer cells in vitro, including aggressive glioblastoma cells. However, its tumor suppression effects and mechanisms in vivo remain largely unexplored. In this study, we utilized cell culture experiments and an orthotopic transplant brain tumor model in mice to evaluate the impact of PEITC on tumor growth, physiological changes, and immune cell populations. Our results showed that PEITC significantly reduced the viability of glioma cells while having moderate effects on astrocytes. In vitro, PEITC effectively inhibited cell viability, migration, and invasion in GL-261 cells. In vivo, PEITC treatment led to prolonged survival rates and reduced tumor volumes in mice without significant toxicity. Notably, PEITC increased the populations of natural killer (NK) cells and natural killer T (NKT) cells in peripheral blood, indicating an immunomodulatory effect. Migration Inhibitory Factor (MIF) was identified as a potential direct target of PEITC. Our findings revealed that PEITC significantly reduced MIF expression in GL-261 cells, both in culture and in orthotopic tumor tissue, and decreased MIF-induced cellular signaling. These results suggest that PEITC has potential to be a therapeutic agent for glioblastoma by inhibiting tumor growth and modulating the immune response through MIF suppression.
Insights
Phenethyl isothiocyanate (PEITC) shows promise for glioblastoma treatment. This compound inhibits cancer cell growth and migration, prolongs survival in mice, and modulates immune cells, potentially via Migration Inhibitory Factor (MIF) suppression.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Phenethyl isothiocyanate (PEITC) is an isothiocyanate with known anti-cancer properties *in vitro*.
- Its *in vivo* anti-tumor effects and mechanisms, particularly in glioblastoma, are not well understood.
Purpose of the Study:
- To investigate the *in vivo* anti-tumor efficacy and immunomodulatory effects of PEITC on glioblastoma.
- To explore the potential role of Migration Inhibitory Factor (MIF) in PEITC's mechanism of action.
Main Methods:
- Cell culture experiments using glioma and astrocyte cells.
- Orthotopic transplant brain tumor model in mice.
- Analysis of tumor volume, survival rates, immune cell populations (NK, NKT), and MIF expression.
Main Results:
- PEITC significantly inhibited glioma cell viability, migration, and invasion *in vitro*.
- *In vivo*, PEITC reduced tumor volume, prolonged survival, and increased NK and NKT cell populations without significant toxicity.
- PEITC decreased MIF expression in glioma cells and tumor tissue, and reduced MIF-induced signaling.
Conclusions:
- PEITC demonstrates significant anti-tumor activity against glioblastoma *in vivo*.
- PEITC exerts immunomodulatory effects by increasing NK and NKT cells.
- Suppression of MIF is a key mechanism underlying PEITC's therapeutic potential for glioblastoma.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:01Regulation of Hematopoietic Stem Cells